Test. Better. Enhanced NIPT Reporting for Patients with Positive Results

With the marked increase in the use of cell-free DNA screening (cfDNA/NIPT) in clinical practice, many non-invasive prenatal test (NIPT) innovations .. Read more were introduced as screening technology rapidly expanded over the past decade. But which NIPT innovations are likely to tangibly improve outcomes for your practice and patients? Which NIPT innovations improve test performance and bolster confidence knowing a screening result is reliable?. This webinar will present a new bioinformatics metric which will support counseling for patients with positive results. Thomas Westover MD FACOG is currently Chair of the New Jersey Section of the American College of Obstetrics & Gynecology, President of the NJ OBGYN Society, Co-Chair of the New Jersey Hospital Association Statewide Perinatal Safety Collaborative, Chief of Maternal Fetal Medicine at Capital Health System in Trenton, NJ and Associate Professor of MFM and OBGYN at Cooper Medical School Rowan University in Camden, NJ. Before joining Integrated Genetics, she worked as a prenatal genetic counselor for 8 years at New Jersey Perinatal Associates at Saint Barnabas Medical Center in Livingston, NJ. For more than 25 years, Integrated Genetics, a member of the LabCorp Specialty Testing Group, has been a pioneer in offering a true continuum of care in reproductive genetic testing from screening to diagnosis, and hereditary cancer testing services.